These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 9673252)

  • 1. Antibody responses to capsular polysaccharide backbone and O-acetate side groups of Streptococcus pneumoniae type 9V in humans and rhesus macaques.
    McNeely TB; Staub JM; Rusk CM; Blum MJ; Donnelly JJ
    Infect Immun; 1998 Aug; 66(8):3705-10. PubMed ID: 9673252
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antigenic determinants of Staphylococcus aureus type 5 and type 8 capsular polysaccharide vaccines.
    Fattom AI; Sarwar J; Basham L; Ennifar S; Naso R
    Infect Immun; 1998 Oct; 66(10):4588-92. PubMed ID: 9746554
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Monoclonal antibodies with specificities for Streptococcus pneumoniae group 9 capsular polysaccharides.
    Kolberg J; Jones C
    FEMS Immunol Med Microbiol; 1998 Apr; 20(4):249-55. PubMed ID: 9626929
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protective immunity of pneumococcal glycoconjugates.
    Lee CJ; Lee LH; Frasch CE
    Crit Rev Microbiol; 2003; 29(4):333-49. PubMed ID: 14636043
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structural characterization of Streptococcus pneumoniae serotype 9A capsule polysaccharide reveals role of glycosyl 6-O-acetyltransferase wcjE in serotype 9V capsule biosynthesis and immunogenicity.
    Calix JJ; Saad JS; Brady AM; Nahm MH
    J Biol Chem; 2012 Apr; 287(17):13996-4003. PubMed ID: 22367197
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunogenicity in mice of pneumococcal glycoconjugate vaccines using pneumococcal protein carriers.
    Lee CJ; Wang TR; Frasch CE
    Vaccine; 2001 Apr; 19(23-24):3216-25. PubMed ID: 11312018
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Production, binding characteristics and protective immunity of monoclonal antibody to pneumococcal type-9V conjugate.
    Lee CJ; Karpas A; Wang TR; Kosaka T; Koizumi K
    Microbiol Immunol; 1996; 40(11):857-65. PubMed ID: 8985941
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cross-immunogenicity of pneumococcal group 9 capsular polysaccharides in adult volunteers.
    Szu SC; Lee CJ; Parke JC; Schiffman G; Henrichsen J; Austrian R; Rastogi SC; Robbins JB
    Infect Immun; 1982 Mar; 35(3):777-82. PubMed ID: 7068216
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of an opsonin inhibition assay for evaluation of complex polysaccharide protective epitopes.
    McNeely T; Luo S; Manger W; Herber W; Schofield T; Tan C; Newman K; Sadoff J; Donnelly J; Cross A
    Vaccine; 2006 Mar; 24(11):1941-8. PubMed ID: 16307833
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of cross-reactive antibodies with low opsonophagocytic activity for Streptococcus pneumoniae.
    Nahm MH; Olander JV; Magyarlaki M
    J Infect Dis; 1997 Sep; 176(3):698-703. PubMed ID: 9291318
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Streptococcus pneumoniae type 14 polysaccharide-conjugate vaccines: length stabilization of opsonophagocytic conformational polysaccharide epitopes.
    Laferriere CA; Sood RK; de Muys JM; Michon F; Jennings HJ
    Infect Immun; 1998 Jun; 66(6):2441-6. PubMed ID: 9596700
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Significant variation in serotype-specific immunogenicity of the seven-valent Streptococcus pneumoniae capsular polysaccharide-CRM197 conjugate vaccine occurs despite vigorous T cell help induced by the carrier protein.
    Kamboj KK; Kirchner HL; Kimmel R; Greenspan NS; Schreiber JR
    J Infect Dis; 2003 May; 187(10):1629-38. PubMed ID: 12721943
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunologic epitope, gene, and immunity involved in pneumococcal glycoconjugate.
    Lee CJ; Wang TR; Tai SS
    Crit Rev Microbiol; 1997; 23(2):121-42. PubMed ID: 9226111
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Response to a heptavalent conjugate Streptococcus pneumoniae vaccine in children with recurrent infections who are unresponsive to the polysaccharide vaccine.
    Sorensen RU; Leiva LE; Giangrosso PA; Butler B; Javier FC; Sacerdote DM; Bradford N; Moore C
    Pediatr Infect Dis J; 1998 Aug; 17(8):685-91. PubMed ID: 9726341
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of Neisseria meningitidis serogroup W135 polysaccharide-tetanus toxoid conjugate vaccines made by periodate activation of O-acetylated, non-O-acetylated and chemically de-O-acetylated polysaccharide.
    Gudlavalleti SK; Lee CH; Norris SE; Paul-Satyaseela M; Vann WF; Frasch CE
    Vaccine; 2007 Nov; 25(46):7972-80. PubMed ID: 17936445
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunogenicity of conjugate vaccines consisting of pneumococcal capsular polysaccharide types 6B, 14, 19F, and 23F and a meningococcal outer membrane protein complex.
    Vella PP; Marburg S; Staub JM; Kniskern PJ; Miller W; Hagopian A; Ip C; Tolman RL; Rusk CM; Chupak LS
    Infect Immun; 1992 Dec; 60(12):4977-83. PubMed ID: 1452327
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Location and quantitation of the sites of O-acetylation on the capsular polysaccharide from Streptococcus pneumoniae type 9V by 1H-n.m.r. spectroscopy: comparison with type 9A.
    Rutherford TJ; Jones C; Davies DB; Elliott AC
    Carbohydr Res; 1991 Sep; 218():175-84. PubMed ID: 1802383
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum and salivary anti-capsular antibodies in infants and children vaccinated with octavalent pneumococcal conjugate vaccines, PncD and PncT.
    Nurkka A; Ahman H; Yaich M; Eskola J; Käyhty H
    Vaccine; 2001 Oct; 20(1-2):194-201. PubMed ID: 11567764
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pneumococcal conjugate vaccine primes for polysaccharide-inducible IgG2 antibody response in children with recurrent otitis media acuta.
    Breukels MA; Rijkers GT; Voorhorst-Ogink MM; Zegers BJ; Sanders LA
    J Infect Dis; 1999 May; 179(5):1152-6. PubMed ID: 10191217
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pneumococcal capsular polysaccharide-meningococcal outer membrane protein complex conjugate vaccines: immunogenicity and efficacy in experimental pneumococcal otitis media.
    Giebink GS; Koskela M; Vella PP; Harris M; Le CT
    J Infect Dis; 1993 Feb; 167(2):347-55. PubMed ID: 8421168
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.